Congenital muscular dystrophy
From Wikipedia, the free encyclopedia
 |
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (October 2007) |
 |
To comply with Wikipedia's quality standards, this article may need to be rewritten. Please help improve this article. The discussion page may contain suggestions. |
 |
This article or section is in need of attention from an expert on the subject. Please help recruit one or improve this article yourself. See the talk page for details. Please consider using {{Expert-subject}} to associate this request with a WikiProject |
| Congenital muscular dystrophy Classification and external resources |
|
| ICD-10 | G71.2 |
|---|---|
| ICD-9 | 359.0 |
| eMedicine | neuro/549 |
Congenital muscular dystrophy (CMD) is the term used to describe muscular dystrophy that is present at birth. CMD describes a number of autosomal recessive diseases of muscle weakness and possible joint deformities, present at birth and slowly progressing. Life expectancies for affected individuals vary, although some forms of CMD do not affect life span at all.
All such known dystrophies are genetically recessive and result from mutations in a variety of different genes, including those encoding the laminin-α2 chain, fukutin-related protein, LARGE and fukutin, amongst others. Currently there is no cure. Physical and occupational therapy, surgery, wheelchairs and other assistive technology may be helpful.
[edit] Classification
A classification for CMDs had been proposed in 2004 by Muntoni and Voit, based on genetic mutation.[1]
- Genes encoding for structural proteins of the basal membrane or extracellular matrix of the skeletal muscle fibres.
- Laminin-α2–deficient CMD (MDC1A)
- Ullrich CMD (UCMDs 1, 2 and 3)
- Integrin-α7 deficiency (ITGA7)
- Genes encoding for putative or demonstrated glycosyltransferases, that in turn affect the glycosylation of dystroglycan, an external membrane protein of the basal membrane.
- Walker-Warburg syndrome
- MEB disease
- Fukuyama CMD (FCMD)
- CMD plus secondary laminin deficiency 1 (MDC1B)
- CMD plus secondary laminin deficiency 2 (mutation in fukitin-related protein, MDC1C)
- CMD with mental retardation and pachygyria (mutation in LARGE, MDC1D)
- Rigid spine with muscular dystrophy Type 1 (RSMD1): deficiency of selenoprotein-N, an endoplasmic reticulum protein of unknown function.
[edit] References
- ^ Muntoni F, Voit T (2004). "The congenital muscular dystrophies in 2004: a century of exciting progress". Neuromuscul. Disord. 14 (10): 635–49. doi:. PMID 15351421.
[edit] External links
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||
